Hims Hers Stumbles Open as Regulatory Damage Hits Outlook
Hims & Hers Health fell after guiding Q1 2026 revenue below expectations, citing a $65 million headwind from regulato...
Using Index Level To Forecast Direction offers a structured method to translate index signals into actionable forecasts.
18,459 articlesHims & Hers Health fell after guiding Q1 2026 revenue below expectations, citing a $65 million headwind from regulato...
Rocket Lab posted solid Q4 FY2025 revenue above estimates, while warning that the Neutron program faces a timeline sh...
Nu Holdings has shown impressive growth, but the true challenge lies in weathering a credit cycle. This guide explain...
Investors are weighing AMDs AI bets against its OpenAI ties and the broader AI spending boom. This guide breaks down ...
Markets wobble as U.S. military actions in Iran escalate costs. Analysts warn the real burden may extend well beyond ...
As Verastem prepares for its 2025 earnings outlook, investors should focus on cash runway, collaboration milestones, ...
A major insider sale at LegalZoom prompts questions for investors. This guide breaks down what the move could mean, h...
When a tech behemoth trims a smaller stake, it prompts questions about risk, strategy, and opportunity. This guide ex...
Investors are weighing the upside of autonomous trucking against cost, timing, and risk. This article breaks down the...
A landmark Nvidia-backed investment could be a game changer for Nebius shareholders. This in-depth look breaks down w...
Honda is recalibrating its EV plan amid slower demand, while REV Group seals a Terex acquisition, creating a pivotal ...
Meta Platforms is considering cutting up to 20% of its workforce to fund AI infrastructure through 2028. The move mir...